期刊文献+

播散性浅表性光线性汗孔角化症21例临床病理分析 被引量:2

Clinical and histopathological features of 21 cases with disseminated superficial actinic porokeratosis
暂未订购
导出
摘要 目的探讨播散性浅表性光线性汗孔角化症临床和组织病理学特点。方法回顾性分析本科1995年1月~2012年1月间断收治的21例播散性浅表性光线性汗孔角化症患者的临床和组织病理学资料。结果 21例患者中男女比例为1.1∶1(男11例,女10例)。20岁前发病者13例(61.91%),(20~50)岁7例(33.33%),>50岁1例(4.76%),平均发病年龄18.36岁。皮损位于曝光部位,累及面部者10例(47.62%),累及颈部者9例(42.86%),累及上肢者19例(90.48%),累及下肢者7例(33.33%),累及躯干者6例(28.57%)。其中4例有家族史(占19.05%)。3例合并有系统疾病。组织病理资料分析均可见典型的角化不全柱,其下方颗粒层减少或消失。结论播散性浅表性光线性汗孔角化症20岁前发病多见,男女发病率大致相当,皮损位于暴露部位。组织学上以表皮角质层内典型的角化不全柱伴其下方颗粒层减少或消失为特征。 Objective To analyze the clinical and histological features of disseminated superficial actinic porokeratosis. Methods The clinical and histopathological data of 21 cases with disseminated superficial actinic porokeratosis in our department from January 1995 to January 2012 were collected and retrospectively analyzed. Results The clinical data have shown that the ratio of male to female was 1.1 : 1 patients whose onset ages were under 20 years ; 7 patients were 20 - 50 years old, and 1 patients was over 50 years old ; the mean age of onset was 18.36 years. It affected only sun-exposed areas which include face (10 cases), neck (9 cases), upper extremities (19 ea- ses), lower extremities (7 cases) and trunk ( 6 cases). Of these patients four cases ( 19.05 % ) had family history, three cases accompa- nied with systemic diseases. Histopathologic examinations commonly presented a eornoid lamella overlying an absent granular layer. Con- elusion Disseminated superficial actinic porokeratosis almost exclusively involved sun-exposed areas of the skin and mostly developed before age 20 years. The distinctive histopathological feature was a column of parakeratotic cells (known as the eornoid lamella) overlying an absent granular laye.
出处 《皮肤病与性病》 2012年第3期125-126,共2页 Dermatology and Venereology
关键词 播散性浅表性光线性汗孔角化症 临床 病理 Disseminated superficial actinic porokeratosis Clinic Pathology
  • 相关文献

参考文献11

  • 1Chernosky ME, Freeman RG. Disseminated superficial actinic poro- keratosis (DSAP) [J]. Arch Dermatol, 1967, 96(6) : 611-624.
  • 2Xia JH, Yang YF, Deng H, et al. Identification locus disseminated superficial actinic porokeratosis at chromosome 12q23.2-24.1. [ J]. J Invest Dermatol, 2000, 114(6) : 1071-1074,.
  • 3Xia K, Deng H, Xia JH, et al. A novel locus (DSAP2) for dissemi- nated superficial actinic porokeratosis maps to chromosome 15q25.1- 26.1. [J]. Br J Dermatol, 2002, 147(4) : 650-654.
  • 4张正华,赵敬军,刘维达.播散性浅表性光线性汗孔角化症一家系11例[J].中华医学遗传学杂志,2001,18(4):321-321. 被引量:3
  • 5Sertznig P, yon Felbert V, Megahed M. Porokeratosis: present con- cepts [J]. J Eur Acad Dermatol Venereol, 2012, 26(4) : 404-412.
  • 6Zhang Z, Niu Z, Wang Y, et al. Association of SSH1 Mutations With Disseminated Superficial Actinic Porokeratosis in Chinese Pedigrees (Re- sponse to Frank et al. ) [J]. Hum Murat, 2007, 25(12) : 1243-1244.
  • 7Kawara S, Oiso N, Kawada A. Disseminated superficial actinic poro- keratosis in a patient undergoing treatment with long-term narrowband ultraviolet B for psoriasis [ J]. J Dermatol, 2011,38 (6) :585-587.
  • 8Jang YH, Chun SJ, Kang WH, et al. Eruptive disseminated superfi- cial actinic porokeratosis in an immunocompetent host: is this associ- ated with herpes simplex virus or bacterial infection [ J ] ? J Am Acad Dermatol, 2004, 51 (6) : 1018-1019.
  • 9Doherty CB, Krathen RA, Smith-Zagone MJ,et al. Disseminated su- perficial actinic porokeratosis in black skin [ J ]. Int J Dermatol, 2009, 48(2) : 160-161.
  • 10Lee HR, Han TY, Son SJ, et ah Squamous cell carcinoma develo- ping within lesions of disseminated superficial actinic porokeratosis [J]. Ann Dermatol, 201~, 23(4) : 536-538.

二级参考文献14

  • 1Flanagan N, Boyadjiev SA, Harper J, et al. Familial craniosynostosis,anal anomalies, and porokeralosis: CAP syndrome. J Med Genet, 1998,35(9) :763-766.
  • 2Magee JW, McCalmont TH, LeBoit PE. Overexpression of p53 tumor suppressor protein in porokeratosis. Arch Dermatol, 1994, 130(2): 187-190.
  • 3Urano Y, Susaki S, Ninomiya Y,et al. Immunohistochemical detection of P53 tumor suppressor protein in porokeratosis. J Dermatol, 1996, 23 ( 5 ):365-368.
  • 4Ninomiya Y, Urano Y, Yoshimoto K, et al. P53 gene mutation analysis in porokeratosis and porokeratosis-associated squamous cell carcinoma. J Dermatol Sci, 1997,14(3): 173-178.
  • 5Xia JH, Yang YF, Deng H, et al. Identification of a locus for disseminated superficial actinic porokeratosis at chromosome 12q23.2-24.1. J Invest Dermatol, 2000,11:(6):1071-1074.
  • 6Mizukawa Y, Shiohara T. Porokeratosis in patients with hepatitis C virus infection: does hepatitis C vixus infection provide a link between porokeratosis and immunosuppression? Br J Dermatol, 1999,141 ( 1 ): 163-164.
  • 7Kawakami T, Saito D, Takahashi K. Overexpression of p21waf/cip1 immunohistochemical staining in Bowen′s disease, but not in disseminated superficial porokeratosis. Br J Dermatol, 1999,141(4) :647-651.
  • 8Quinn AG. p21watYcip1 and p53 expression in the skin-intertwined but not inseparable. Br J Dermatol, 1999,141(4) :613-616.
  • 9Nelson C, Cowper S, Morgan M. p53, mdm-2, and p21 waf-1 in the pokeokeratoses. Am J Dermatopathol, 1999,21(5) :420-425.
  • 10Happle R. Cancer proneness of linear porokeratosis may be explanned by allelic loss. Dermatology, 1997,195( 1 ) :20-25.

共引文献5

同被引文献6

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部